- Report
- March 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,381GBP
- Report
- July 2023
- 255 Pages
Global
From €4555EUR$4,795USD£3,906GBP
- Report
- January 2022
- 218 Pages
Global
From €4559EUR$4,799USD£3,909GBP
- Report
- September 2020
- 220 Pages
Global
From €4654EUR$4,899USD£3,991GBP
- Report
- December 2019
- 381 Pages
Global
From €4274EUR$4,499USD£3,665GBP
- Report
- May 2023
- 202 Pages
Global
From €4703EUR$4,950USD£4,032GBP
- Report
- February 2018
- 192 Pages
Global
From €594EUR$625USD£509GBP
€1188EUR$1,250USD£1,018GBP
- Report
- February 2023
- 180 Pages
Global
From €5653EUR$5,950USD£4,847GBP
- Report
- August 2020
- 142 Pages
Global
From €3943EUR$4,150USD£3,381GBP
- Report
- May 2024
- 185 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- May 2024
- 182 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- April 2024
- 185 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- May 2024
- 200 Pages
From €3943EUR$4,150USD£3,381GBP
- Report
- November 2021
- 545 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- November 2021
- 1165 Pages
Global
From €5700EUR$6,000USD£4,888GBP
- Report
- May 2023
- 147 Pages
Global
From €5699EUR$5,999USD£4,887GBP
Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research.
Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more